Select a community
All Communities
Home > Community Treatment Reports > Rizatriptan Treatment Report
What is Rizatriptan?

Rizatriptan is an antimigraine agent available under the brand names Maxalt-MLT®; Maxalt®. It is used in the treatment of acute treatment of migraine with or without aura.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Migraine 38 11
Other 15 4
Migraine Headaches 13 0
Headaches 6 3
Pain 3 0
General health 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
3 18%
Mild
6 35%
None
8 47%

Most commonly reported side effects

Drowsiness
5 29%
tiredness
3 18%
Jaw pain
1 6%
Tingling in face
1 6%
Pain, all over (generalized)
1 6%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Rizatriptan. See all 11 dosages ►

  10 mg as needed 10mg as needed 1 as needed 200mg as needed 20 mg as needed 2 10mg as needed 5 mg as needed 5mg as needed as needed mg as needed 10 mg daily
  1 Number of Patients: 1 41 Number of Patients: 41 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 14 Number of Patients: 14 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5  

Stop Reasons

Why Patients Stopped Taking Rizatriptan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
4 29% Doctor's advice: 29%
Did not seem to work
4 29% Did not seem to work: 29%
Expense
2 14% Expense: 14%
Other
2 14% Other: 14%
Not indicated
1 7% Not indicated: 7%
Personal research
1 7% Personal research: 7%
Side effects too severe
1 7% Side effects too severe: 7%
Course of treatment ended
1 7% Course of treatment ended: 7%

See all 13 patients who’ve stopped taking Rizatriptan

Duration See details about how long patients take this treatment ▼

Currently Taking Rizatriptan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
6
10
7
27

Stopped Taking Rizatriptan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
2
3
1
1
4

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
13 76%
Usually
2 12%
Sometimes
2 12%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 6%
A little
3 18%
Not at all
13 76%

Cost

Paid out of pocket

$200+
0 0%
$100-199
1 6%
$50-99
1 6%
$25-49
4 24%
< $25
5 29%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.